Resources

Despite significant advances in kidney care over the past 20 years, efforts to improve therapy for Type 1 diabetes patients with kidney dysfunction remain unsuccessful….

Transplanting human umbilical cord blood-derived endothelial progenitor cells (EPCs) has been found to “significantly accelerate” wound closure in diabetic mouse models…. 

For individuals of white European descent, certain variations of the gene HMGA1 are associated with Type 2 diabetes….

In men, FPG definitions yielded more incident cases of diabetes than HbA1c definitions, in contrast with women….

The investigational drug Bydureon used to treat Type 2 diabetes under development by Eli Lilly & Co., Amylin Pharmaceuticals Inc. and Alkermes Inc. failed to meet primary endpoints in a 26-week study…. 

Individuals with A1c ≥5.6% have an increased risk for future diabetes….

A research team, led by La Jolla Institute scientist Joel Linden, Ph.D., has shed new light on the problem of insulin resistance, and identified the key participants in a molecular pathway that holds therapeutic promise for reducing the severity of Type 2 diabetes…. 

Having an accumulation of fat in your liver cells may raise your risk of developing Type 2 diabetes regardless of the fat in other places of your body….

An analysis of previous studies indicates that among patients with a history of cardiovascular disease, but not hypertension, use of high blood pressure medication…. 

Diabetic Neuropathic Disorders John R. White, Jr., PharmD, PA R. Keith Campbell, PharmB, MBA, CDE Travis E. Sonnett, PharmD Adaptation by Matthew Szabo, PharmD (candidate) Overview The two most common forms of neuropathy that affect diabetes patients are diabetic peripheral neuropathy (DPN) and diabetic autonomic neuropathy (DAN).